Id |
Subject |
Object |
Predicate |
Lexical cue |
T34 |
0-15 |
Sentence |
denotes |
Acknowledgement |
T35 |
16-118 |
Sentence |
denotes |
The authors wish to thank Ashley Headrick for help in preparing and submitting the commentary article. |
T36 |
120-127 |
Sentence |
denotes |
Funding |
T37 |
128-541 |
Sentence |
denotes |
This work was funded by the 10.13039/100000738Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development Merit Review Awards 2I01 BX000226 and IMMA-010-19F (AAV), Senior Research Career Scientist Award 1IK6BX004209 (AAV) and the 10.13039/100000060National Institute of Allergy and Infectious Diseases award R44AI122574 (AAV). |
T38 |
542-641 |
Sentence |
denotes |
The contents do not represent the views of the Department of Veterans Affairs or the US Government. |
T39 |
643-677 |
Sentence |
denotes |
Availability of data and materials |
T40 |
678-802 |
Sentence |
denotes |
The datasets used and/or analyzed during previous studies are available from the corresponding author on reasonable request. |
T41 |
804-824 |
Sentence |
denotes |
Author contributions |
T42 |
825-900 |
Sentence |
denotes |
The commentary article was written, edited and reviewed by AAV, HO and RMR. |
T43 |
901-949 |
Sentence |
denotes |
All authors read and approved the final article. |
T44 |
951-970 |
Sentence |
denotes |
Competing Interests |
T45 |
971-1187 |
Sentence |
denotes |
Drs. Vandenbark, Offner, Meza-Romero, and OHSU have a significant financial interest in Artielle ImmunoTherapeutics, Inc., a company that may have a commercial interest in the results of this research and technology. |
T46 |
1188-1345 |
Sentence |
denotes |
This potential conflict of interest has been reviewed and managed by the OHSU and VA Portland Health Care System Conflict of Interest in Research Committees. |